ubmslateRN-logo-ubm

RN Mobile Menu

Search form

Topics:

Rheumatology Network

Opioid Toxicity

One in three U.S. adults with arthritis are prescribed opioids, researchers reported at ACR 2016. This slideshow highlights the best of opioid-related studies from ACR 2016.  (Espresso. ©SubbotinaAnna/Shutterstock.com); (Prescription bottle. ©Burlingham/Shutterstock.com); (Prescription pad. ©megaflopp/Shutterstock.com); (Antidepressants. ©LeaRojec/Shutterstock.com)

Recent Content

Researchers reporting at the American Society of Hematology annual meeting this week say there is a link between a treatment for autoimmune disease and the development of leukemia.

Women who have rheumatoid arthritis might benefit from treatment with denosumab over alendronate. According to a new study, denosumab is more effective at bone healing.

Doctor and patients perceive the importance of lupus medications differently. In this article, we feature a UAB-derived decision aid that highlights key considerations.

Less than half of patients with systemic lupus erythematosus reach low disease activity. Why? Experts say focus on disease duration, phenotype and other accepted predictive factors.

(©zlikovec/Shutterstock.com)

New research shows that a periodontal pathogen may trigger autoimmunity in rheumatoid arthritis. It appears to trigger a cascade that is known to lead to autoantigen citrullination in the RA joint.

Good early management of pulmonary hypertension in patients with systemic sclerosis leads to better outcomes and fewer complications, researchers report.

By clicking Accept, you agree to become a member of the UBM Medica Community.